Everyday Health on MSN
A daily drugstore multivitamin may slow biological aging
Taking a daily multivitamin for two years slowed biological aging by four months, based on several DNA-based biomarkers — but a healthy lifestyle still matters.
Morning Overview on MSN
Graphite flakes could shrink X-ray machines and revolutionize bioimaging
Researchers at Nanyang Technological University have demonstrated that ordinary graphite flakes, some as thin as 10 ...
Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
Researchers simulated nearly every molecule in a bacterial cell — and then watched the cell grow and reproduce.
Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient’s cells. However, most genetic disorders are caused by dozens or even thousands of ...
Most lethal mutations in wild fruit flies are driven by newly transferred jumping genes, not small DNA errors, according to a new study from Duke University. The findings, published in PLOS Biology, ...
News-Medical.Net on MSN
AI trained on 9 trillion DNA letters predicts harmful mutations and designs new genomes
By Hugo Francisco de Souza Trained on genomic data spanning the tree of life, Evo 2 reveals how artificial intelligence can ...
KOMODO-1 first-in-human clinical trial of BBI-940 open for enrollment $108 million in cash provides runway into the second half of 2028, through expected clinical proof-of-concept readout for KOMODO-1 ...
Atlas Data Storage, a pioneer of production-scale DNA data storage, today announce a new strategic partnership to accelerate the development of digital data storage using synthetic DNA. The ...
A Coma Pattern-Based Autofocusing Method Resolves Bacterial Cold Shock Response at Single-Cell Level
Imaging-based single-cell physiological profiling holds great potential for uncovering fundamental bacterial cold shock response (CSR) mechanisms, but its application is impeded by severe focus drift ...
KOMODO-1 first-in-human clinical trial of BBI-940 open for enrollment $108 million in cash provides runway into the second half of 2028, through expected clinical proof-of-concept readout for KOMODO-1 ...
Amid Iran's missile onslaught on Israel and a growing online debate about the war, an old clip of President Trump praising Barron Trump's ability to use a laptop has resurfaced and ignited a biting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results